Hua Bai

Zhejiang Hisun Chemical Co., Ltd. is a Chinese company that manufactures and markets agricultural chemicals. The private company is based in Taizhou, China.

Part of Zhejiang Hisun Pharmaceutical Co., Ltd., Hisun Pharmaceutical (Hangzhou) Co., Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. The company is based in Hangzhou, China.

Part of Zhejiang Hisun Pharmaceutical Co., Ltd., Zhejiang Pharmaceutical Industry Co. Ltd. is a pharmaceutical company based in Hangzhou, China. Zhejiang Pharmaceutical Industry Co. is a Chinese pharmaceutical company that specializes in drug wholesale, animal medicine sales, and the sale of health food, pre-packaged food, and chemical products. The company also sells medical devices, pharmaceutical machinery and accessories, pharmaceutical packaging materials, cosmetics, disinfectants, and daily necessities. The company has a sales network covering 26 provinces, municipalities, and autonomous regions in China, and has more than 200 commercial customers, 100 chain headquarters, and 5,000 terminal stores outside the province. The company was acquired by Zhejiang Hisun Pharmaceutical Co., Ltd. on March 29, 2013 for $12.15 million.

Part of Zhejiang Hisun Pharmaceutical Co., Ltd., Hisun Pharmaceuticals USA, Inc. is an American pharmaceutical company that offers a broad portfolio of generics through leveraging the diverse and expansive capabilities of its parent company. The company actively seeks to acquire products, technologies, or companies with strategic value in the market. Hisun also offers an extensive portfolio of active pharmaceutical ingredients (API) with over 130 sold to more than 60 countries. Additionally, the company operates a fully integrated network of four manufacturing facilities and is dedicated to acquiring, developing, and commercializing novel pharmaceutical and biotechnology products for various markets.

Zhejiang Hisun Group Co. Ltd. manufactures and markets pharmaceutical products. The company provides anti-infective drugs for endocrine regulation in the domestic market. The firm was founded in 1956 and is headquartered in Taizhou, China.